G01N 33/70
Involving creatine or creatinine
Official title: involving creatine or creatinine
G01N33/70 (Involving creatine or creatinine) appears on 164 US grants and 283 published applications in this corpus.
Search patents in G01N- Granted patents
- 164
- Published applications
- 283
- Assignees
- 183
- Inventors
- 647
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 2 | 0 |
| 1979 | 0 | 0 |
| 1980 | 2 | 0 |
| 1981 | 2 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 2 | 0 |
| 1985 | 3 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 3 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 4 | 0 |
| 1997 | 4 | 0 |
| 1998 | 2 | 0 |
| 1999 | 5 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 1 |
| 2003 | 2 | 1 |
| 2004 | 0 | 5 |
| 2005 | 2 | 4 |
| 2006 | 3 | 4 |
| 2007 | 1 | 1 |
| 2008 | 0 | 3 |
| 2009 | 2 | 7 |
| 2010 | 4 | 4 |
| 2011 | 2 | 5 |
| 2012 | 0 | 4 |
| 2013 | 1 | 5 |
| 2014 | 5 | 7 |
| 2015 | 6 | 15 |
| 2016 | 4 | 14 |
| 2017 | 9 | 18 |
| 2018 | 1 | 12 |
| 2019 | 6 | 22 |
| 2020 | 9 | 37 |
| 2021 | 12 | 17 |
| 2022 | 16 | 24 |
| 2023 | 11 | 19 |
| 2024 | 13 | 22 |
| 2025 | 8 | 23 |
| 2026 | 4 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Heart failure marker4 Aug 2026US 12,699,104 B2National University Corporation Kagawa University
- Cell-free biosensors to detect creatinine, creatine, and sarcosine3 Mar 2026US 12,566,184 B2Georgia Tech Research Corporation
- Compositions and methods for improved calibration accuracy of creatinine/creatine sensors and uses thereof20 Jan 2026US 12,529,673 B2Instrumentation Laboratory Company
- Biocide compositions compatible with enzyme biosensors and methods of use thereof6 Jan 2026US 12,516,365 B2Instrumentation Laboratory Company
- Prescription of remote patient management based on biomarkers14 Oct 2025US 12,442,825 B2B.R.A.H.M.S GmbH
- Method for evaluating onset risk of non-alcoholic fatty liver disease, and biomarkers8 Oct 2026US 2026/0309702 A1Shimadzu Corporation
- Upregulated metabolite found in brain cancer17 Sep 2026US 2026/0276648 A1Board of Regents, The University of Texas System
- Analysis of bodily emissions10 Sep 2026US 2026/0266806 A1Outsense Diagnostics Ltd.
- Kit and method of determining the presence or amount of creatinine20 Aug 2026US 2026/0243782 A1Hong Kong Centre for Cerebro-Cardiovascular Health Engineering Limited
- Use of urine biomarkers for determining the risk of subjects having subclinical acidosis30 Jul 2026US 2026/0219285 A1Aarhus Universitet
Most cited
By later US patents
- Multi-zoned reaction vessel having pressure-actuatable control means between zones440US 4,426,451 AEastman Kodak Company · 1984
- Device for preventing assay interference using silver or lead to remove the interferant204US 5,945,345 AMetrika, Inc. · 1999
- Prognostic testing of organs intended for transplantation97US 6,375,613 B1Breonics, Inc. · 2002
- Diagnosis of autism and treatment therefor80US 5,686,311 AThe Children's Mercy Hospital · 1997
- Method and apparatus for chemical analysis using reactive reagents dispersed in soluble film57US 4,387,164 AFMC Corporation · 1983